About Us
VUZE Medical was incorporated in 2017 in Israel and is financed privately. Milestones so far include high accuracy and speed on an anatomical model (2018) and in cadaver surgeries (2019-2020), a first US Patent (2020, with five more since), first European and Asian patents (2021), FDA 510(k) submission (2021), successful first-in-human surgery (late 2021), FDA 510(k) clearance for minimally-invasive thoracolumbar fixation and augmentation (2022), the completion of a highly-successful twenty-patient clinical trial (early 2023) and cadaveric proofs of concept for pain therapy and open surgery (mid 2023).
Team
Extensive Experience and a Strong Track Record
A veteran team brings strong domain expertise in adding computer guidance to common manual interventions. Our two prior endeavors have each become a Standard of Care in its respective field: superDimension (now Medtronic) in bronchoscopies with 1,000 installations worldwide, and SyncVision (now Philips) in coronary catheterizations with 4,000 installations worldwide.
left to right:
Sasha Steinberg algorithms
Sigi Elazar UI & UX
Rivay Mor algorithms
Koby Zakaeim application engineering
Neta Stern software
Yoav Stein software
Levona Schriger testing & support
Asaf Omer QA & RA
Ran Cohen CTO
David Tolkowsky CEO
Product
Company
Contact
VUZE Medical Ltd.
13 Zarhin St., Entrance A, Floor 7
Ra’anana 4366241, Israel
info@vuzemedical.com
Copyright © 2023 VUZE Medical Ltd. All rights reserved. Proprietary. Patents granted. Patents pending. The VUZE system, VUZE software and Dynamic Online Image Registration (DOLIR) are trademarks of VUZE Medical.